[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"infection-soft-tissue\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:infection-soft-tissue":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":4},"100533019","path-study-people-with-injecting-related-infections-assessing-treatment-outcomes-for-those-who-are-hospitalised-100533019",false,"NCT06220370","PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.","PATH","Inclusion Criteria:\n\n1. Have voluntarily signed the informed consent form,\n2. 18 years of age or older,\n3. Injected drugs within the last 6 months,\n4. Admitted to hospital with invasive bacterial or fungal infection, a. Examples of invasive infection include: bloodstream infection, bone and joint infection (osteomyelitis, septic arthritis, discitis), central nervous system infection (epidural abscess, meningitis), deep abscess (i.e., brain, liver, muscle, spleen), endovascular infection (infective endocarditis, septic thrombophlebitis, mycotic aneurysm, septic embolism), skin or soft tissue infection (necrotising fasciitis, myositis),\n\nExclusion Criteria:\n\n1\\) Is unable or unwilling to provide informed consent or abide by the requirements of the study.","ALL","18 Years",{"count":19,"type":20},300,"ESTIMATED","OBSERVATIONAL","We seek to characterise the burden and outcomes of and understand the current experience of people who inject drugs admitted to hospital with invasive injecting-related infections, in order to implement and evaluate strategies to improve completion of therapy and reduce patient-directed discharges, with ultimate benefit to the patient and health service.",[24,25,26,27,28,29],"Invasive Fungal Infections","Invasive Bacterial Infection","Injection Site Infection","Infection, Bacterial","Infection, Fungal","Infection, Soft Tissue",[31,32,33],"Antimicrobial therapy","Patient-directed discharge","Injection-related infectious diseases","NOT_YET_RECRUITING","2024-02-18",{"date":37,"type":38},"2024-02-20","ACTUAL",{"date":40,"type":20},"2024-03-01",{"date":42,"type":20},"2029-03-01",{"name":44,"class":45},"Kirby Institute","OTHER_GOV"]